Literature DB >> 25113039

The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.

Xiao-Lin Li1, Jian-Jun Li, Yuan-Lin Guo, Cheng-Gang Zhu, Ping Qing, Na-Qiong Wu, Bo Xu, Run-Lin Gao.   

Abstract

BACKGROUND: High-density lipoprotein (HDL) has cardioprotective properties. Each HDL particle has a few molecules of apolipoprotein A-I (apoA-I) and carries various amounts of cholesterol. The ratio of high-density lipoprotein cholesterol (HDL-C) to apoA-I may reflect mean HDL particle size. HYPOTHESIS: HDL-C/apoA-I ratio may provide more information than HDL-C and apoA-I in predicting myocardial injury following elective percutaneous coronary intervention (PCI).
METHODS: We prospectively enrolled 2529 consecutive patients who underwent elective PCI and assessed the relationships of preprocedural HDL-C, apoA-I, and their ratio with peak cardiac troponin I (cTnI) within 24 hours after PCI.
RESULTS: Neither HDL-C nor apoA-I levels showed significant association with postprocedural cTnI elevation, whereas HDL-C/apoA-I ratio was associated with postprocedural cTnI elevation above 3 up to 30 × upper limit of normal (ULN), with the lowest risk in the middle quintile (all P values for quadratic term were <0.05). Adjusted odds ratios (95% confidence interval) of postprocedural cTnI >3 × ULN for quintile 1 to 5 of HDL-C/apoA-I ratio were: 1 (reference), 0.81 (0.62-1.07), 0.57 (0.43-0.75), 0.65 (0.49-0.85), and 0.76 (0.58-1.01), respectively, and the adjusted odds ratios of postprocedural cTnI >30 × ULN for quintile 1 to 5 of HDL-C/apoA-I ratio were: 1 (reference), 0.81 (0.49-1.361), 0.42 (0.23-0.77), 0.66 (0.38-1.14), and 0.82 (0.49-1.38), respectively.
CONCLUSIONS: There was a U-shaped association between HDL-C/apoA-I ratio and myocardial injury following PCI.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25113039      PMCID: PMC6649364          DOI: 10.1002/clc.22308

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  40 in total

Review 1.  Remodelling of high density lipoproteins by plasma factors.

Authors:  K A Rye; M A Clay; P J Barter
Journal:  Atherosclerosis       Date:  1999-08       Impact factor: 5.162

Review 2.  High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.

Authors:  A von Eckardstein; J R Nofer; G Assmann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

3.  Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

Authors:  Christa Meisinger; Hannelore Loewel; Wilfried Mraz; Wolfgang Koenig
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

4.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

Authors:  G Walldius; I Jungner; I Holme; A H Aastveit; W Kolar; E Steiner
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

5.  Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.

Authors:  Joseph B Selvanayagam; Italo Porto; Keith Channon; Steffen E Petersen; Jane M Francis; Stefan Neubauer; Adrian P Banning
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

6.  Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.

Authors:  M J Ricciardi; E Wu; C J Davidson; K M Choi; F J Klocke; R O Bonow; R M Judd; R J Kim
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

7.  Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.

Authors:  B Agerholm-Larsen; A Tybjaerg-Hansen; P Schnohr; R Steffensen; B G Nordestgaard
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

8.  Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL.

Authors:  M S Gowri; D R Van der Westhuyzen; S R Bridges; J W Anderson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

9.  Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport.

Authors:  Agueda C M Zaratin; Eder C R Quintão; Andrei C Sposito; Valéria S Nunes; Ana Maria Lottenberg; Richard E Morton; Eliana C de Faria
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

10.  Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.

Authors:  M Miller; A Seidler; P O Kwiterovich; T A Pearson
Journal:  Circulation       Date:  1992-10       Impact factor: 29.690

View more
  1 in total

1.  Association between High-Density Lipoprotein Cholesterol to Apolipoprotein A-I Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.

Authors:  Hangkai Huang; Jinghua Wang; Lei Xu; Min Miao; Chengfu Xu
Journal:  Int J Endocrinol       Date:  2021-06-04       Impact factor: 3.257

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.